Cell Source Market Cap

Cell Source has a market cap or net worth of $48.33 million as of March 6, 2026. Its market cap has increased by 59.63% in one year.

Market Cap

48.33M

Enterprise Value

58.41M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.99

Market Cap Chart

Since July 1, 2014, Cell Source's market cap has increased from 36.03M to 48.33M, an increase of 34.14%. That is a compound annual growth rate of 2.55%.

Market Cap History

Date	Market Cap	% Change
Mar 5, 2026	48.33M	98.00%
Dec 31, 2025	24.41M	59.96%
Dec 31, 2024	15.26M	-14.98%
Dec 27, 2023	17.95M	-40.09%
Dec 29, 2022	29.96M	-30.67%
Dec 31, 2021	43.22M	-32.39%
Dec 31, 2020	Pro	Pro
Dec 27, 2019	Pro	Pro
Dec 20, 2018	Pro	Pro
Dec 27, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Arch Biopartners	38.82M
ZIVO Bioscience	37.00M
Vicapsys Life Sciences	48.56M
Harvard Apparatus Regenerative Technology	30.77M
Nuo Therapeutics	67.60M
HST Global	70.56M
Finch Therapeutics Group	21.28M
Provectus Biopharmaceuticals	20.59M

Market Cap Rankings